Impact of the Food and Drug Administration's antipsychotic black box warning on psychotropic drug prescribing in elderly patients with dementia in outpatient and office‐based settings

Abstract

After the warning, there was a small decline in the use of atypical antipsychotics and no evidence of substitution of other psychotropic medications.